AtriCure is also awaiting results of an IDE clinical trial testing an approach to endocardial catheter ablation in the persistent and longstanding persistent AFib populations. In that approach, a surgeon performs closed-chest epicardial ablation followed by an electrophysiologist performing endocardial catheter ablation. The Convergent trial involves AtriCure's EPi-Sense coagulation device.